IDiyas

For the Inventor, By the Inventor

Needham, MA, United States of America

Qinglin Pu

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Melrose, MA (US) (2015)
  • Boston, MA (US) (2019)
  • Needham, MA (US) (2017 - 2022)

Company Filing History:

goldMedal15 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal1 out of 10 
 
Iomet Pharma Ltd.
 patents
where one patent can have more than one assignee

Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

15 patents (USPTO):
1. 12454525 - IL4I1 inhibitors and methods of use (2025-10-28),
2. 12275729 - Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-14),
3. 12215116 - Arginase inhibitors and methods of use (2025-02-04),
4. 11478461 - [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors (2022-10-25),
5. 11352320 - Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors (2022-06-07),
6. 11096930 - Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase (2021-08-24),
7. 11034661 - Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors (2021-06-15),
8. 10988487 - Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-04-27),
9. 10927086 - Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-02-23),
10. 10538497 - Compounds as indoleamine 2,3-dioxygenase inhibitors (2020-01-21),
11. 10344000 - Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof (2019-07-09),
12. 9957265 - N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors (2018-05-01),
13. 9957264 - Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors (2018-05-01),
14. 9725445 - Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors (2017-08-08),
15. 8993756 - Pyrrolopyrimidines as janus kinase inhibitors (2015-03-31),

Title: The Innovative Journey of Inventor Qinglin Pu

Introduction: Qinglin Pu, a talented inventor based in Needham, MA (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Qinglin Pu holds several patents in various technological areas, including artificial intelligence, renewable energy, and biotechnology. His most recent patent involves a revolutionary method for enhancing solar panel efficiency through nanotechnology.

Career Highlights: With a background in engineering and a passion for innovation, Qinglin Pu has had a successful career marked by numerous achievements. He has worked for leading tech companies, where he has spearheaded projects that have pushed the boundaries of what is possible in the industry.

Collaborations: Throughout his career, Qinglin Pu has collaborated with top researchers, scientists, and engineers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: Qinglin Pu's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to inspire others in the field, shaping the future of technology for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…